SOURCE: Revolutions Medical Corp.

Revolutions Medical Corp.

September 22, 2009 08:45 ET

Revolutions Medical to Debut Evolutionary MRI Software Line on International Stage

High Profile Trade Intro Expected to Initiate Demand, Ready Market for Commercial Launch

MOUNT PLEASANT, SC--(Marketwire - September 22, 2009) - Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it will debut its evolutionary MRI software suite at the Radiological Society of North America (RSNA) annual meeting at McCormick Place in Chicago on November 29th - December 4th.

President Tom O'Brien, who will be attending his 28th RSNA annual meeting, stated, "We are proud to announce that Revolutions Medical will very soon meet a major milestone on the road to commercialization; we will be introducing our unique 3D, color and automatic segmentation software and technology on the imaging industry's largest stage. I had the honor of being part of the team that first launched Technicare/Johnson and Johnson's MRI system in the early 80s, as well as other MRI technology breakthroughs over the years. No product has excited me as much since then as do our unique MRI tools RevColor, RevDisplay and Rev3D, tools designed to enhance MRI diagnostic confidence while saving hospitals time and money. MRI volume is growing at a much faster rate than are the radiologist/neuro radiologist ranks can read them, creating both a significant need and opportunity for our products."

More than 40,000 medical imaging professionals are members of the RSNA, and the Association hosts the world's largest annual radiology meeting. There were nearly 60,000 attendees at the 2008 event, including almost 20,000 physicians and over 10,000 healthcare professionals. Revolutions Medical will be available at this year's event at corner booth #6604.

To be added to the Revolutions Medical investor email list, please email with RMCP in the subject line.

About Revolutions Medical Corporation (

Revolutions Medical's products include the Rev Vac safety syringe (FDA Approved), safety blood drawing device and safety IV catheter. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D and automatic segmentation of images.


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact Information